15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
50
Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1.

Argenta Discovery
46
A reversed sulfonamide series of selective RORc inverse agonists.

Argenta Discovery
62
From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor.

Argenta Discovery
23
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1.

Argenta Discovery
11
Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactions.

Argenta Discovery
47
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors.

Argenta Discovery
38
Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists.

Argenta Discovery
47
Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.

Argenta Discovery
25
Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.

Argenta Discovery
13
Quinazoline and benzimidazole MCH-1R antagonists.

Argenta Discovery
37
Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.

Argenta Discovery
25
Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.

Argenta Discovery
13
A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor.

Argenta Discovery
6
Structure-activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists.

Argenta Discovery
41
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study.

Argenta Discovery